Combination therapy with amisulpride and antidepressants: Clinical observations in case series of elderly patients with psychotic depression

Antonis Politis, George N. Papadimitriou, Christos G. Theleritis, Constantin Psarros, Constantin R. Soldatos

Research output: Contribution to journalArticle

Abstract

Psychotic depression is classified as a clinical subtype of major depressive disorder. The combination of an antidepressant with an antipsychotic agent has been demonstrated to be efficacious for the treatment of psychotic depression. However, in elderly patients with psychotic depression, little information is available on the efficacy of such combinations. Therefore, we have evaluated combination treatment for 5 weeks with amisulpride and antidepressants in non-demented elderly patients with psychotic depression. Eleven patients were treated with either citalopram 20-40 mg/day (n = 5) or mirtazapine 30-60 mg/day (n = 6), and amisulpride 75-100 mg/day for 5 weeks. Clinical status was evaluated at baseline and after 3 and 5 weeks using the Brief Psychiatric Rating Scale (BPRS), the Hamilton Depression Rating Scale-17 items (HDRS) and the Clinical Global Impression Scale (CGI-S). In 5 of the 11 patients there was remission of depression, while in another 5 patients there was partial remission of depression and in one patient there was no remission. Finally, there was resolution of psychotic symptoms in all the patients involved. One patient developed tremor and rigidity but insisted on continuing with the drug since her psychopathology has improved considerably after the addition of amisulpride to antidepressant treatment. In conclusion, some of the elderly patients with psychotic depression may benefit from the combination of amisulpride and antidepressant pharmacotherapy.

Original languageEnglish (US)
Pages (from-to)1227-1230
Number of pages4
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume32
Issue number5
DOIs
StatePublished - Jul 1 2008
Externally publishedYes

Fingerprint

Antidepressive Agents
Depression
Therapeutics
Brief Psychiatric Rating Scale
sultopride
Citalopram
Major Depressive Disorder
Tremor
Psychopathology
Antipsychotic Agents
Drug Therapy
Pharmaceutical Preparations

Keywords

  • Amisulpride
  • Antidepressants
  • Elderly
  • Psychotic depression

ASJC Scopus subject areas

  • Biological Psychiatry
  • Pharmacology

Cite this

Combination therapy with amisulpride and antidepressants : Clinical observations in case series of elderly patients with psychotic depression. / Politis, Antonis; Papadimitriou, George N.; Theleritis, Christos G.; Psarros, Constantin; Soldatos, Constantin R.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 32, No. 5, 01.07.2008, p. 1227-1230.

Research output: Contribution to journalArticle

Politis, Antonis ; Papadimitriou, George N. ; Theleritis, Christos G. ; Psarros, Constantin ; Soldatos, Constantin R. / Combination therapy with amisulpride and antidepressants : Clinical observations in case series of elderly patients with psychotic depression. In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2008 ; Vol. 32, No. 5. pp. 1227-1230.
@article{356d8ab1a34a40d19bb8637ef1013d95,
title = "Combination therapy with amisulpride and antidepressants: Clinical observations in case series of elderly patients with psychotic depression",
abstract = "Psychotic depression is classified as a clinical subtype of major depressive disorder. The combination of an antidepressant with an antipsychotic agent has been demonstrated to be efficacious for the treatment of psychotic depression. However, in elderly patients with psychotic depression, little information is available on the efficacy of such combinations. Therefore, we have evaluated combination treatment for 5 weeks with amisulpride and antidepressants in non-demented elderly patients with psychotic depression. Eleven patients were treated with either citalopram 20-40 mg/day (n = 5) or mirtazapine 30-60 mg/day (n = 6), and amisulpride 75-100 mg/day for 5 weeks. Clinical status was evaluated at baseline and after 3 and 5 weeks using the Brief Psychiatric Rating Scale (BPRS), the Hamilton Depression Rating Scale-17 items (HDRS) and the Clinical Global Impression Scale (CGI-S). In 5 of the 11 patients there was remission of depression, while in another 5 patients there was partial remission of depression and in one patient there was no remission. Finally, there was resolution of psychotic symptoms in all the patients involved. One patient developed tremor and rigidity but insisted on continuing with the drug since her psychopathology has improved considerably after the addition of amisulpride to antidepressant treatment. In conclusion, some of the elderly patients with psychotic depression may benefit from the combination of amisulpride and antidepressant pharmacotherapy.",
keywords = "Amisulpride, Antidepressants, Elderly, Psychotic depression",
author = "Antonis Politis and Papadimitriou, {George N.} and Theleritis, {Christos G.} and Constantin Psarros and Soldatos, {Constantin R.}",
year = "2008",
month = "7",
day = "1",
doi = "10.1016/j.pnpbp.2008.03.011",
language = "English (US)",
volume = "32",
pages = "1227--1230",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Combination therapy with amisulpride and antidepressants

T2 - Clinical observations in case series of elderly patients with psychotic depression

AU - Politis, Antonis

AU - Papadimitriou, George N.

AU - Theleritis, Christos G.

AU - Psarros, Constantin

AU - Soldatos, Constantin R.

PY - 2008/7/1

Y1 - 2008/7/1

N2 - Psychotic depression is classified as a clinical subtype of major depressive disorder. The combination of an antidepressant with an antipsychotic agent has been demonstrated to be efficacious for the treatment of psychotic depression. However, in elderly patients with psychotic depression, little information is available on the efficacy of such combinations. Therefore, we have evaluated combination treatment for 5 weeks with amisulpride and antidepressants in non-demented elderly patients with psychotic depression. Eleven patients were treated with either citalopram 20-40 mg/day (n = 5) or mirtazapine 30-60 mg/day (n = 6), and amisulpride 75-100 mg/day for 5 weeks. Clinical status was evaluated at baseline and after 3 and 5 weeks using the Brief Psychiatric Rating Scale (BPRS), the Hamilton Depression Rating Scale-17 items (HDRS) and the Clinical Global Impression Scale (CGI-S). In 5 of the 11 patients there was remission of depression, while in another 5 patients there was partial remission of depression and in one patient there was no remission. Finally, there was resolution of psychotic symptoms in all the patients involved. One patient developed tremor and rigidity but insisted on continuing with the drug since her psychopathology has improved considerably after the addition of amisulpride to antidepressant treatment. In conclusion, some of the elderly patients with psychotic depression may benefit from the combination of amisulpride and antidepressant pharmacotherapy.

AB - Psychotic depression is classified as a clinical subtype of major depressive disorder. The combination of an antidepressant with an antipsychotic agent has been demonstrated to be efficacious for the treatment of psychotic depression. However, in elderly patients with psychotic depression, little information is available on the efficacy of such combinations. Therefore, we have evaluated combination treatment for 5 weeks with amisulpride and antidepressants in non-demented elderly patients with psychotic depression. Eleven patients were treated with either citalopram 20-40 mg/day (n = 5) or mirtazapine 30-60 mg/day (n = 6), and amisulpride 75-100 mg/day for 5 weeks. Clinical status was evaluated at baseline and after 3 and 5 weeks using the Brief Psychiatric Rating Scale (BPRS), the Hamilton Depression Rating Scale-17 items (HDRS) and the Clinical Global Impression Scale (CGI-S). In 5 of the 11 patients there was remission of depression, while in another 5 patients there was partial remission of depression and in one patient there was no remission. Finally, there was resolution of psychotic symptoms in all the patients involved. One patient developed tremor and rigidity but insisted on continuing with the drug since her psychopathology has improved considerably after the addition of amisulpride to antidepressant treatment. In conclusion, some of the elderly patients with psychotic depression may benefit from the combination of amisulpride and antidepressant pharmacotherapy.

KW - Amisulpride

KW - Antidepressants

KW - Elderly

KW - Psychotic depression

UR - http://www.scopus.com/inward/record.url?scp=49849100323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49849100323&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2008.03.011

DO - 10.1016/j.pnpbp.2008.03.011

M3 - Article

C2 - 18442877

AN - SCOPUS:49849100323

VL - 32

SP - 1227

EP - 1230

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 5

ER -